- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06115889
Smart Taiko-Drum Playing for Older Adults With Cognitive Frailty
Smart Taiko-Drum Playing for Older Adults With Cognitive Frailty for Improving Cognitive and Physical Functions: A Randomized Controlled Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study design:
- Randomized Control Trial
Participants:
- Community-dwelling older adults with cognitive frailty
Setting:
- Community centres for seniors
Intervention
- Playing Smart Taiko three times/weeks x 16 weeks for 30 - 45 minutes each session
- A Smart Taiko Drumming system has been developed for older adults to play the drumming game with their preferred music genres.
Waitlist-control group
- Will receive usual care
Health outcomes that will be assessed three times at baseline, during (8th week) and immediate post-intervention (16th week)
- cognitive functions
- physical functions
- mental health
- physical frailty status
- body composition
Feasibility evaluation
- recruitment
- retention
- satisfactory survey
- compliance with the survey
- safety
- focus group intervention with participants
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Daphne Sze Ki Cheung, PhD
- Phone Number: 27664534
- Email: daphne.cheung@polyu.edu.hk
Study Contact Backup
- Name: Daphne Sze Ki Cheung, PhD
- Phone Number: 27664534
- Email: daphne.s.k.cheung@gmail.com
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- School of Nursing, The Hong Kong Polytechnic University
-
Contact:
- Daphne Cheung, PhD
- Phone Number: +852 27664534
- Email: daphne.cheung@polyu.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- with cognitive frailty
- without a diagnosis of a neurological or psychiatric condition that could affect cognitive function
- live independently or with partial assistance
- with pre-frailty
Exclusion Criteria:
- with a significant sensory or motor impairment that would preclude participation in the intervention
- are unable to understand or follow instructions due to language or hearing impairment
- have already been in another cognitive or physical intervention programme within the past three months
- are taking medications that could significantly affect cognitive or physical functions
- with any medical condition or treatment that would contraindicate participation in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Smart Taiko Drumming Group
Smart Taiko Drumming
|
Participants will play drumming with the developed Smart Taiko Drumming System for 30-45 minutes three times per week for 16 weeks, in addition to usual care.
|
|
No Intervention: Usual Care Waitlist Control Group
Usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attrition rate
Time Frame: Through study completion, an average of 2 years
|
Overall attrition rate-defined as the proportion of participants at defined study points who discontinued the intervention or were lost to follow-up (calculated as number of participants that withdraw (numerator)/number of participants randomised (denominator)).
|
Through study completion, an average of 2 years
|
|
Recruitment rate
Time Frame: Through study completion, an average of 2 years
|
The Proportion of eligible people recruited (= proportion of people randomised/proportion of people eligible).
|
Through study completion, an average of 2 years
|
|
Satisfaction to the intervention
Time Frame: Through study completion, an average of 2 years
|
Satisfaction questionnaire, including questions of "Does the game provide an engaging environment for training?",
"Do you think the exercise intensity suits you?"
|
Through study completion, an average of 2 years
|
|
Intervention Completion Rate
Time Frame: Through study completion, an average of 2 years.
|
Overall intervention completion rate -defined as the proportion of participants who completed the allocated intervention with a minimum of 80% attendance. Calculated as number of participants allocated to the intervention that completed the minimum attendance (numerator)/number of participants allocated to treatment (denominator). |
Through study completion, an average of 2 years.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety concerns of the intervention
Time Frame: Through study completion, an average of 2 years.
|
Any adverse events during the intervention period
|
Through study completion, an average of 2 years.
|
|
Overall cognitive function
Time Frame: 6 months
|
The Hong Kong version of the Montreal Cognitive Assessment with the possible score from 0 - 30, with a higher score indicates better cognition
|
6 months
|
|
Executive function
Time Frame: 6 months
|
Frontal Assessment Battery Total score with the possible score from 0 - 18, higher scores indicating better performance
|
6 months
|
|
Memory
Time Frame: 6 months
|
Fuld Object Memory Evaluation Total Storage score ranges from 0 -50, with a higher score indicate better memory.
|
6 months
|
|
Verbal fluency
Time Frame: 6 months
|
Modified Verbal Fluency Test will be used to assess the verbal fluency, with no highest score.
Higher score indicates better verbal fluency.
|
6 months
|
|
Mobility and Balance
Time Frame: 6 months
|
Time Up and Go Test will be used.
The test measures how long it takes to stand up, walk a distance of 10 feet, turn, walk back, and sit down again.
Shorter time indicate better mobility and balance.
|
6 months
|
|
Handgrip strength
Time Frame: 6 months
|
To be measured with a hand-held Jamar Hand Dynamometer
|
6 months
|
|
Functional capacity and endurance
Time Frame: 6 months
|
Six-Minute-Walk-Test. The longer distance walked indicates better functional capacity and endurance.
|
6 months
|
|
Mental wellbeing
Time Frame: 6 months
|
Hospital Anxiety and Depression Scale is a 14-item measure designed to assess anxiety and depression symptoms.
The total score ranges from 0 - 42, with a higher score indicates poorer mental wellbeing.
|
6 months
|
|
Happiness
Time Frame: 6 months
|
Subjective Happiness Scale will be used.
The four items will be responded on 7-Likert scale.
The total is the average score of the 4-items, ranges from 1 - 7. Higher score is more happy.
|
6 months
|
|
Loneliness
Time Frame: 6 months
|
De Jong Gierveld Loneliness Scale will be used.
In this 6-item scale, three statements are made about 'emotional loneliness' and three about 'social loneliness'.
Total score ranged from 0-6, with a higher score means higher loneliness.
|
6 months
|
|
Frailty status
Time Frame: 6 months
|
FRAIL scale with the possible score range from 0 - 5. Higher score refers to higher frailty.
|
6 months
|
|
Body composition - Body weight
Time Frame: 6 months
|
Bioelectrical impedance analysis will be used for measuring body composition using the InBody S10, Korea except those with contradictions, such as wearing a pacemaker.
|
6 months
|
|
Body composition - Skeletal muscle mass
Time Frame: 6 months
|
Bioelectrical impedance analysis will be used for measuring body composition using the InBody S10, Korea except those with contradictions, such as wearing a pacemaker.
|
6 months
|
|
Body composition - body mass index
Time Frame: 6 months
|
Body weight in kg is divided by square of body height
|
6 months
|
|
Body composition - body fat mass
Time Frame: 6 months
|
Bioelectrical impedance analysis will be used for measuring body composition using the InBody S10, Korea except those with contradictions, such as wearing a pacemaker.
|
6 months
|
|
Body composition - percent body fat.
Time Frame: 6 months
|
InBody S10, Korea except those with contradictions, such as wearing a pacemaker.
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate
Time Frame: 6 months
|
Will be monitored for evaluating the intervention process
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Daphne Sze Ki Cheung, PhD, The Hong Kong Polytechnic University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P0046219
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Impairment
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
University of EdinburghNHS LothianNot yet recruitingCognitive Impairment | Anesthesia | Cognitive Impairment, Mild | Anesthesia Brain Monitoring | Cognitive Impairment, Progressive | Anesthesia Depth MonitoringUnited Kingdom
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
-
Universidad de ZaragozaRecruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive ImpairmentSpain
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Region SkaneLund University; Berry LabCompletedMemory Impairment | Cognitive Impairment, MildSweden
-
Sunnybrook Health Sciences CentreRecruitingMild Cognitive Impairment | Vascular Cognitive ImpairmentCanada
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University of HawaiiRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
Clinical Trials on Smart Taiko Drumming
-
University of StellenboschCompletedDepressive Disorder | Bipolar Disorder
-
Yale UniversityNational Institute of Mental Health (NIMH)Enrolling by invitation
-
Royal College of MusicCompletedIndividuals Experiencing Mild or Moderate Mental Health IssuesUnited Kingdom
-
University of UtahCompleted
-
KK Women's and Children's HospitalInstitute of Mental Health, Singapore; National University of Singapore; Lions... and other collaboratorsActive, not recruitingDepression | Quality of Life | Sleep | Blood Pressure | GripSingapore
-
Yale UniversityNational Institute of Mental Health (NIMH)Enrolling by invitation
-
Arizona State UniversityActive, not recruitingStress | Anxiety Acute | Depression and Quality of Life | Stress in Parents of Autistic ChildrenUnited States
-
Wake Forest University Health SciencesCompletedHematopoietic Cell TransplantUnited States
-
Johns Hopkins UniversityCompletedParkinson Disease | Huntington DiseaseUnited States
-
Yale UniversityNational Center for Complementary and Integrative Health (NCCIH); Howard University and other collaboratorsRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Caregiver | Peer-bonded CaregiverUnited States